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JP-8 is a kerosene~ased fuel consisting of a complex mixture of hundreds of components from a number of hydrocarbon classes, including straight chain alkanes, branched chain alkanes, cycloalkanes, diaromatics and naphthalenes . Human exposures to JP-8 in the vapor, aerosol and liquid forms all have the potential to be harmful. Situations where fuel becomes aerosolized have the greatest potential to be a hazard via inhalation (Pleil et al., 2000) . Both aerosol and liquid forms of JP-8 have the potential to cause local and systemic effects with prolonged or repeated skin contact; JP-8 exposure has been shown to result from aircraft engine starts at low ambient temperatures as a result of incomplete combustion inhalation (Pleil et al., 2000) . It may be inhaled, irritate the eyes or result in skin irritation and absorption.
Potential JP-8 dermal exposure scenarios are:
1) prolonged contact with the skin of ground personnel through soaked clothing 2) splashes during refueling or fuel handling, 3) handling engine parts which are coated with fuel, 4) coming in contact with sides of fuel tank during fuel tank maintenance operations, and 5) coming in contact with fuel leaks on the underside of the aircraft or on the ramp.
Many JP-8 components interact in a number of ways, such as competing for the same metabolic enzymes, or modifying each others' partitioning into various tissues of the body. and then model these interactions. However, with the large number of components, this becomes an impossibly complex undertaking. For example, a single type of (simple) binary interaction between 300 components would require the specification of some 10 5 interaction coefficients.
One proposed solution to this problem is to "lump" the components into a fewer number of groups consisting of "similar" chemicals according to some well defined chemical properties or behaviors (such as equivalent carbon number, molecular weight, water solubility, lipid partitioning, vapor pressure, etc.) (US EPA, 1999) . Each group can then be characterized by examining in detail a chosen representative compound of that group; interactions between groups can be examined by studying interactions between these representative compounds. This approach has been advocated, for example, by the Total Petroleum Hydrocarbon (TPH) Criteria
Working Group, which has classified petroleum hydrocarbon fractions into six aliphatic and seven aromatic classes (Gustafson eta/., 1997) .
Although it is useful as perhaps a first approximation (Kenyon eta/., 1996) , there are a number of difficulties with this luq~ping approach, including the problem that suitable categorization criteria may be suitable for one type of behavior (such as blood-air partitioning), but may not be suitable for another (such as blood-tissue distribution). In addition, the composition of a group may change with time so that the properties ofthe group of chemicals as a whole may no longer be reflected by those of the originally chosen representative compound. We therefore propose an alternative approach that retains some of the advantages of the "lumping" process, while allowing the changing properties of the mixture to be mathematically characterized.
PBPK models for a number of individual components of JP-8, such as benzene, xylene, toluene and nonane, have been developed, and in addition, models of the interactions of up to five component mixtures of chemicals have been studied (Haddad eta/., 1999; Tardif et al., 1997) . A key result of these studies is that a complete description of the interactive processes can be obtained by simultaneously tracking all the binary interactions in the mixture (i.e., interactions of 2 one chemical with another). Higher order interactions (i.e. interactions between three or more chemicals) are automatically taken into account in this way.
The present approach to developing a quantitative framework for assessing tissue exposure to specific components of a complex mixture, in the presence of all the other components, is suggested by the observed behavior of JP-8 components as they penetrate the skin following dermal exposure to JP-8 (Robinson and McDougal, 2000) . It was shown that skin penetration of JP-8 constituents was determined by their specific chemical properties (in this case, octanol water partition coefficients), together with the properties of the JP-8 vehicle, in the same way as has been previously observed from other vehicles such as water (Wilschut eta!., 1995) . The JP-8 vehicle could be considered essentially the same for all components because each contributed only a small fraction (less than a couple of percent) ofthe total.
In the approach to be presented here for each interactive process, each component is assumed to interact with a single "vehicle", where the vehicle is characterized as some kind of well-defined "average" of all the other components ofthe mixture. The problem is to determine both qualitatively and quantitatively how to characterize the interactions of the component with this vehicle. This involves answering two questions:
• What are the appropriate parameters that characterize the mixture (vehicle) as a whole in relation to the interaction of interest?
• What is the appropriate way to average these parameters over the components of the mixture?
Once a particular mixture is characterized in terms of a set of parameters representing a particular interactive process, changes in the mixture composition (as a result, for example, of kinetic processes in the body, or of weathering in the environment) can be conveniently tracked in terms of specific changes in these calculated (average) parameter values with time. In this way, relevant properties of different mixtures can be distilled, visualized and compared.
VEHICLE EFFECTS ON DERMAL ABSORPTION
We begin with a summary of our results on the dermal penetration of JP-8 (Robinson and McDougal, 2000) . Briefly, static diffusion cells with 4.9 cm 2 skin exposure area were used to The log ofthe dermal penetration coefficient Kp was observed to have a linear dependence on lipophilicity as estimated from the the log-octanol-water partition coefficient K 01 w (with slight dependence on molecular weight, MW) (see Figure 1 ):
Log Kow
Figure 1. Log plot of skin penetration coefficient (log Kp) against log octanol-water partition coefficient (log Kow) for 13 components of JP-8 measured with rat skin in static diffusion cells (McDougal eta/., 2000). The linear regression is given by equation 1 in the text.
This semi-empirical relation can be used to predict (estimate) Kp values for other JP-8
components (McDougal and Robinson, 2002) . In contrast to the penetration of compounds from an aqueous vehicle (Potts and Guy, 1992) , in which skin permeability generally increased with the compound's lipophilicity, in the case of JP-8 vehicle, the more lipophilic compounds penetrated the skin at a lower rate. This is consistent with other results of more hydrophilic compounds preferentiallypartitioning into the stratum corneum from a more lipophilic (rather than hydrophilic) vehicle. Nevertheless, the behaviors are similar in that there was an observed linear dependence of Kp on log K 0 1w, and that the nature of the vehicle in each case determines this dependence. To a first approximation at least, JP-8 can be regarded as a simple vehicle, without taking into accoont its individual components and their separate interactions. Similar results are obtained for silastic sheeting, suggesting the possibility of using this membrane as a skin surrogate for predicting vehicle effects on dermal penetration.
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The key here is that there are a sufficiently large number of components in JP-8 and each of them makes up a very small fraction of the total (1% or 2% at most). Thus even though the vehicle for each component is lightly different (total JP-8 minus that component), to a first approximation the vehicle remains the same.
This conceptual approach is also applicable to different kinds of potential interactions, including metabolism (competitive inhibition, non-competitive inhibition, uncompetitive inhibition, enzyme induction), distribution (competition for protein binding sites, alterations of blood flow) and absorption (vehicle effects in dermal absorption, alterations of skin permeability, alteration of pulmonary ventilation rate). In the remainder of this report, we will focus on competitive metabolic inhibition of JP-8 components.
INTERACTIONS VIA COMPETITIVE INHIBITION
In a recent series of studies, Tardif and colleagues have explored the pharmacokinetic interactions of up to five related compounds, based on the notion that PBPK modeling provides a unique framework that can account for higher order pharmacokinetic interactions based on information from binary mixtures (Haddad eta/., 1999; Tardif et al., 1997) . In particular, they studied the metabolic interactions between benzene (B), toluene (T), m-xylene (X), ethylbenzene (E) (all minor components of JP-8) and dichloromethane (D). Analysis of the blood kinetic data suggested that competitive metabolic inhibition ofP450 2El was the most likely interaction mechanism for these compounds. The metabolic inhibition constants K; for each binary interaction was determined and the values are summarized in Figures 2 and 3 and in Table 2 below. Most components of JP-8 are metabolized by cytochrome P-450 2E-1 ias part of the Phase 1 detoxification process. Individual components are thus subject to competitive metabolic inhibition. Based on these observations, in order to describe the pharmacokinetic behavior of JP-
..--"\ 8/ we need to at least take into account metabolic i:r:t~~ra~t!~ns between the components, specifically competitive metabolic inhibition ofP450 2El)
We thus make a number of general hypotheses for competitive enzyme inhibition in sufficiently complex mixtures of metabolically similar components.
• · The interconnection of PBPK models of individual substances, via the mechanisms of binary interactions, is enough to predict the higher order interactions present in the mixture.
• Complex mixtures can often be approximated as pseudo-binary systems, consisting of the compound of interest plus a single interacting complex "vehicle" with well-defined, composite properties.
....
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Generalizing the results of Tardif et al. (1997) and Haddad eta!. (1999) 
where c 101 is the total concentration of the mixture in the blood (excluding component x, which for many complex mixtures may make a negligible contribution to the total), and (4) is an effective inhibition constant for compound x in the presence of other mixture components i, and where /; is the fraction of the mixture with an inhibition constant K;x.
is the harmonic mean of the individual inhibition constants for the rest i*X Kix of the mixture (weighted according to relative abundances in the mixture). Note also that equation (3) is identical in form to that which describes the interactions of just two components in a binary mixture. 10 Thus, in a complex mixture with interactions via competitive metabolic inhibition, the metabolic rate of each component can be described as if it were part of a binary combination. The total mixture concentration replaces that of the single competitor, and the inhibition constant is given by the harmonic mean o(the individual (binary) inhibition constants.
Note that, in general, the harmonic mean K x changes as the relative composition of the mixture changes (i.e., as each.fi changes). For example, as JP-8_is metabolized, some components may be ll!"t)~ metabolized to a larger extent than others, and will~ their relative fraction fall (and vice versa).
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(However, ifthere happens to be no correlation between the rate of metabolism and inhibition K;x, then metabolism will result in no systematic change in the average value K x ).
Because of the large number of components involved, it is impossible in practice to characterize each pairwise interaction in a complex mixture in terms of its individual inhibition constant. An
C/t!• 1M
"'-alternative approach suggests'its'C!ffrom an examination ofFigure 2, which shows the / 1-t~ distribution of inhibition constants given in Table 2 
If the limit in which the total mixture concentration is much less than the harmonic mean of the inhibition constants (c 101 << Kx ), the metabolic rate becomes (from Equation 3):
12 .
In this limit, the pharmacokinetics of each of the components are the same as if other chemicals
were not present; interactions between components become negligible. Figure (5) with time as components of the mixture are subject to differential effects ofpharmacokinetic processes.
In particular (and in contrast to the case in which there are just a few components), c 101 cannot be modeled directly (since it is a mixture of hundreds of components, each one of which would have to be simulated). It can, however, be either controlled (kept approximately constant) or measured experimentally.
The model can be tested (verified, validated) experimentally, although this has not been done at this stage. The Appendix outlines a proposed protocol to validate the present model using male Fisher F-344 rats. The rats will be dosed intraperitoneally by means of surgically implanted ALZET™ osmotic pumps, available in a variety of sizes and pumping rates. This method of exposure is chosen because:
• It is resource efficient and convenient.
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• The focus of the studies is on the kinetics oqhe compounds, particularly metabolism.
Specific route of entry effects are not of interest at this stage. Intraperitoneal implantation is preferred over sub-cutaneous exposure in order to maximize the concentrations circulated to the liver before exhalation in the lungs.
• We are not at this stage attempting to mimic real-life exposure scenarios (which may be inhalation and/or dermal) t'd the modifications in relative composition of the fuel due to . b . se m.
I ectlve a sorption.
Concentrations in both blood and tissue will be able to be maintained at or near steady-state for extended periods of time. Dosing solutions will be as follows:
• Neat component: nonane or benzene: 0, 50, 100 mglkg; 5 dosing groups • Mixture: nonane with benzene spiked at 0, 50, 100 mglkg each in JP-8 (750 mglkg); 5 dosing groups
Both the neat JP-8 and the mixtures will be emulsified (5% w/w) in a 6% solution ofVolpo20 in physiological saline, to minimize the potential interaction of the JP-8 with pump and the rat tissue.
Blood samples (100 f.LL) will be collected from the tail vein following dosing at 1, 2, 4, 8, 12 and 24 h (and, ifnecessary, daily thereafter), and analyzed fortotaljet fuel and specific components by gas chromatography/flame ionization detection and headspace analysis. Tissue samples will include fat, liver, brain and muscle. Serial tissue samples (1h and 24h) will be taken in the JP-8 dosed groups. In the neat nonane and benzene groups, tissue samples will be taken at the end of the experiment (24 h).
Data from these experiments can be compared with the model predictions (Equations 3 and 4)
for model validation purposes. Experimental data may al~uggest-ways in ~jch t~€l model "stt ucture ean be improved. (Dennison eta/., 2003) . If this were indeed the case, then as more easily metabolized components (and presumably more effective inhibitors) are removed from the mixture, the composition of the mixture will change in a systematic way. The mixture as a whole will drift towards having higher average Km and Ki values and the kinetics will change (slow down) accordingly.
Although we have treated the complex JP-8 mixture as essentially a single lumped compartmen~ nteracting with a specific component of concern/, as more information becomes available, it may be useful to further refine the analysis by considering more than one hydrocarbon "lump".
For example, the aliphatic and aromatic components of the fuel behave sufficiently differently in a number of ways (lipophilicity, volatility, etc.) that they could be treated separately. This difference in behavior between aliphatics and aromatics was noticed, for example, in our earlier skin penetration experiments, in which the JP-8 components formed two distinct clusters based on their calculated dermal penetration coefficients (as a function of molecular weight and octanol-water partition coefficient) (McDougal and Robinson, 2002; Robinson and McDougal, 2000) .
The development of pharmacokinetic models for complex mixtures such as JP-8 presents a specific set of problems due to the large number of interacting components involved. PBPK models of individual components are critically dependent on values for their blood-air and tissue blood coefficients. These may be difficult to measure experimentally due to the large number of ~i chemicals involved, and so algorithms for predicting partition coefficients from more readily 17 available structural and chemical properties have been developed (e.g., Poulin and Krishnan, 1996) , and we are looking at their usefulness for predicting blood-air and tissue-blood partition coefficients for JP-8 components in our model (Sterner eta/., in preparation) . Although this approach is promising in that it obviates the need to experimentally determine blood and tissue partition coefficients for each component in a complex mixture, so far, the results for J:r-8_
/-----f;~dditives, since they are often designed to alter the overall performance characteristics of a fuel, have a relatively large effect on JP-8 properties, particularly in relation to their typically small contribution to the fuel's overall composition. Also, additives (such as the relatively hydrophilic diethylene glycol monomethyl ether, DiEGME) tend to be chemically quite different from the bulk of the fuel. In light of these considerations, additives may ultimately need to be treated separately, rather than lumped with the hydrocarbon components of a fuel.
As with traditional PBPK models of single chemicals, extended PBPK models for complex mixtures (such as the one described here), once appropriately validated, are useful for target site 
I. NON-TECHNICAL SYNOPSIS:
Complex mixtures such as the widely used jet fuel JP-8 often consist of hundreds of individual, though often chemically similar, components. Developing physiologically-based pharmacokinetic (PBPK) models of such complex mixtures by describing each component individually is not feasible due to the large number of components. However, the mixture can often be approximated as a pseudo-binary system, consisting of the compound of interest (that is modeled in detail) plus a single interacting complex vehicle with well-defined, composite properties. We have developed such a model of complex mixtures in which interactions are via competitive metabolic inhibition of a specific enzyme activity. According to this model, the metabolic rate of each component can be described as if it were part of a binary mixture, with the total mixture concentration replacing that of the single competitor, and the effective inhibition constant given by the (concentration-weighted) harmonic mean of the individual (binary) inhibition constants. The purpose of this protocol is to validate this mathematical mixture model for JP-8 with experimental kinetic animal exposures.
II. BACKGROUND:
A. Background:
JP-8 is a kerosene based fuel consisting of a complex mixture of hundreds of components from a number of hydrocarbon classes, including straight chain alkanes, branched chain alkanes, cycloalkanes, diaromatics and napthalenes . Human exposures to JP-8 in the vapor, aerosol and liquid forms all have the potential to be harmful. Situations where fuel becomes aerosolized have the greatest potential to be a hazard via inhalation. Both aerosol and liquid forms of JP-8 have the potential to cause local and systemic effects with prolonged or repeated skin contact. JP-8 exposure has been shown to result from aircraft engine starts at low ambient temperatures as a result of incomplete combustion. It may be inhaled, irritate the eyes or soak clothing and come into prolonged contact with the skin of ground personnel.
Many JP-8 components interact in a number of ways, such as competing for the same metabolic enzymes, or modifying each others' partitioning into various tissues of the body. In order to fully characterize the behavior of any one component, one must simultaneously characterize the effects of all the others. One way to explore these component interactions is to develop physiologically-based pharmacokinetic (PBPK) models of individual chemical components and then model these interactions. However, with the large number of components, this becomes an impossibly complex undertaking.
In a recent series of studies, Tardif and colleagues have explored the pharmacokinetic interactions of up to five related compounds, based on the notion that PBPK modeling provides a unique framework that can account for higher order pharmacokinetic interactions based on information from binary mixtures (Tardif et a/., 1997; Haddad c:t a/., 1999) . In particular, they have otudied the metabolic interactions behveen benzene (B), toluene (T), m-xylene (X), ethylbenzene (E) (all components of JP-8) and dichloromethane (D). Analysis of the blood kinetic data suggested that competitive metabolic inhibition ofP450 2E1 was the most likely interaction mechanism for these compounds.
Generalizing the results of Tardif eta/. (1997) and Haddad eta/. (1999) to a complex mixture of hydrocarbon components such as JP-8, with competitive metabolic inhibition between each pair of components, the ·metabolic rate for a particular component x in a mixture of an arbitrary number of other components i can be written as:
where V~x is the maximal metabolic rate ofx, ex is the concentration ofx, K~ is the (true) MichaelisMenten constant for x, c; and K ix are the concentrations and inhibition constants of each component /, c 101 is the total concentration of the mixture in the blood (excluding component x, which for many complex mixtures may make a negligible contribution to the total), and
is an effective inhibition constant for compound x in the presence of other mixture components i, and where /; is the fraction of the mixture with an inhibition constant Kit·
is the harmonic mean of the individual inhibition constants of the rest of the i¢X Kix mixture (weighted according to their relative abundances in the mixture) (Robinson, 2001 a, b) .
In particular (and in contrast to simple mixtures in which there are just a few components) Cror cannot be modeled directly (since it is of course a mixture of hundreds of components, each one of which would have to be simulated). It can, however, be either controlled (e.g. kept approximately constant) or measured experimentally. The approach we take in the present protocol is to measure C 10 , as the total hydrocarbon content of the blood as estimated by the total area under appropriate GC curves (without identifying individual peaks).
B. Literature Search:
III.
OBJECTIVE/HYPOTHESIS:
The purpose of this protocol is to validate a specific mathematical mixture model for JP-8 in which the components interact via competitive metabolic inhibition of cytochrome P450 2El enzyme in the liver.
IV. MILITARY RELEVANCE:
JP-8 is the battlefield fuel for DoD and NATO countries. It is the standard military fuel for all types of vehicles, including the U.S. Air Force Inventory, and in addition, similar fuels are used extensively in the commercial aviation industry. Human exposures to JP-8 in the vapor, aerosol and liquid forms all have the potential to be harmful. Situations where fuel becomes aerosolized have the greatest potential to be a hazard via inhalation. Both aerosol and liquid forms of JP-8 have the potential to cause local and systemic effects with prolonged or repeated skin contact. JP-8 exposure has been shown to result from aircraft engine starts at low ambient temperatures as a result of incomplete combustion. It may be inhaled, irritate the eyes or soak clothing and come into prolonged contact with the skin of ground personnel.
Other potential dermal exposures to JP-8 are: 1) splashes during refueling or fuel handling , 2) handling engine parts which are coated with fuel, 3) coming in contact with sides of fuel tank during fuel tank maintenance operations, or 4) coming in contact with fuel leaks on the underside of the aircraft or on the ramp.
V. MATERIALS AND METHODS:
A. Experimental Design and General Procedures:
This animal protocol will outline studies that are required to address the above stated objective. The studies described below will be implemented using IPRLs. For all the experiments, male Fisher F-344 rats (Charles River Laboratories) will be ordered to arrive 150-200 gat receipt. All animals have free access to food and water. All animal studies described in this study are conducted in accordance with the principles stated in the "Guide for the Care and Use of Laboratory Animals", National Research Council, 1996, and the Animal Welfare Act of 1966, as amended.
Dosing:
The rats will be dosed intraperitonealy by means of implanted ALZETfM osmotic pumps, available in variety of sizes, pumping rates. ~e pumps will be tested in vitro to make sure that their function is unaffected by the presence of JP-8 and its components. An initial in vivo pilot (rangefinding) study will be conducted (n=5) to make sure that enough JP-8 can be delivered by this method to provide meaningful tissue and blood measurements of the chemicals of interest. The initial choice of pump will have a 2 mL reservoir and provide an infusion rate of 10 JlL!h for a period of 7 days. A smaller pump may be chosen if possible.
This method of exposure is chosen because:
• It is resource efficient and convenient • The focus of the studies is on the kinetics of the compounds, particularly metabolism, and specific route of entry effects are not of interest at this stage. Intrperioneal implantation is preferred over sub-cutaneous exposure in order to maximize the concentrations seen by the liver befun; exhalatiuu iu the luu~:>.
• We are not at this stage attempting to mimic real-life exposure scenarios (which may be inhalation and/or dermal) and the modifications in relative composition of the fuel due to selective absorption
• Concentrations in both blood and tissue will be able to be maintained at or near steady-state for extended periods of time Dosing solutions will be as follows:
• Neat component: nonane, benzene: 0, 50, 100 mg!kg: 5 dosing groups • Mixture: nonane, benzene spiked at 0, 50, 100 mg!kg each in JP-8 (750 mg/kg): 5 dosing groups Both the neat JP-8 and the mixtures will be emulsified (5% w/w) in a 6% solution ofVolpo20 (polyethylene glycol-20 oleyl ether, Croda, Mill Hill PA) in physiological saline, to minimize the potential interaction of the JP-8 with pump and the rat tissue.
Surgical Implantation of Alzet Osmotic Minipump:.
Sterile Alzet Mini-Osmotic pumps will be obtained from the Alza Company, Palo Alto, CA. Prior to implantation of osmotic pumps a small area on the abdominal area is clipped and cleaned with betadine solution veterinary, Povidone-iodine(titratable iodine, 0.5%) is distributed by the Purdue Frederick company ofNorwalk, CT. Sterile equipment will be used at all times (sterilized using steam autoclaving). The pumps will be incubated in 0.9%NaCl overnight in a water bath at body temperature. After the pumps are incubated, the rats will be anesthetized by inhalation of 50%C0 2 /50%0 2 gas mixture from the supplier. A small incision will be made at the prepared site, the pumps will be inserted into the abdomen and the incision closed with surgical staples.
After recover from surgery, each animal will be placed in a whole body metabolism cage for the collection of urine and feces during the course of the study.
Blood samples (100J..1.L) will be collected from the tail vein following dosing at 1, 2, 4, 8, 12 and 24 h (and, if necessary, daily thereafter), and analyzed for total jet fuel and specific components (see Analytical Methods below). Tissue samples will include fat, liver, brain and muscle. Serial tissue samples (1h, 24h) will be taken in the JP-8 dosed groups. In the neat nonane and benzene groups, tissue samples will be taken at the end of the experiment (24h). Serial tissue sampling will increase the number of groups by 10.
Analytical Methods:
A Hewlett-Packard 5890 gas chromatograph with a 5971 series mass spectrometric detector will be used for liquid JP-8 separation and identification work with a 0.25mm X 60m SPB-1 column. JP-8 is a mixture of hundreds of components. Identities will be determined for the components with the larger concentrations. Identities of the smaller concentration components will be found only if they are well separated.
Liquid injections of JP-8 will also be run on a Gas Chromatograph/Flame Ionization Detector for JP-8 separation and quantification. A similar 0.20mm X 60m SJ>B-1 column will be used. JP-8 components of interest will be separated and quantified from the average of several injections. JP-8 and spiked JP-8 samples will be separated and quantified. FID gives similar area/wt response to unsubstituted hydrocarbons. This was checked with six unsubstituted hydrocarbons and confirmed. Therefore, areas will be used to determine the component and total JP-8 sample weights.
A small blood or tissue sample from a JP-8 exposed rat will be placed in a 20 mL headspace vial. A Tekmar 7000/7050 Headspace Sampler will be used for injection from a headspace vial at 140 °C. The sample will separated and quantified on a Varian 3700 Gas Chromatograph /Flame Ionization Detector with a 0.53mm X 30m SPB-1. JP-8 standards will be prepared in headspace vials with control blood or tissue.
r Data Analysis:
The data collected in the present study will be combined with data previously collected in our laboratory (nonane kinetics, and available in the literature in order to further develop and validate a model for mixtures interaction. The mathematical structure of the model, based on competitive inhibition ofP-450 metabolism has already been outlined (Robinson, 2001a, b) . As shown in the Background, this model describes JP-8 as a "lumped" chemical with a total concentration C 10 r and inhibition constants Kx = Kn and Kb for nonane and benzene metabolism respectively (equations 2 and 3). The present data will be used to validate this model and to estimate values for Kn and Kb.
For PBPK modeling, ACSL software (AEgis Technologies, Huntsville, AL) or equivalent will be used.
Animals required Pre-surgery, all rats are cared for by the vivarium staff and maintained in accredited animal rooms.
Post-operative care: animals will be allowed to recover from the surgical implant of the ALZET osmotic minipump. Following surgery, animals will be housed separately in room 18, building 838, and allowed to recover from anesthesia. Recovering animals will be placed on a heating pad and monitored continuously until conscious. Food and water will be provided ad libitum. The animals will be monitored by Tim Bausman/Dick Godfrey, the attending veterinarian, and the VSF staff. A "Research Rodent Surgical Report", and "Clinical Observations Form" will be filled out for each individual rodent by the technician assigned to protocol. Recovered animals will then be returned to room 157 in building 79.
If the animal appears to be experiencing pain or distress that cannot be relieved, it will be euthanized by C0 2 overdose under the supervision of the attending veterinarian. The veterinarian will inform the PI or CO-PI of a decision to carry out euthanasia before killing the animals. The attending veterinarian will have the final authority for ordering euthanasia to be carried out for sick or distressed animals that cannot be relieved through medication or other courses of action.
Once the animal has been euthanized, it will be placed in buffered formalin until necropsy can be performed on the animal. The study endpoint for the animals is euthanasia.
Euthanasia:
Rats will be euthanized by exsanguination following anesthesia.
All procedures will be conducted by Mr. Dick Godfrey.
D. Veterinary Care:
1. Husbandry Considerations:
Receipt, quarantine, and general husbandry will be performed by vivarium personnel in accordance with Vivarium Support Function SOP's and the National Research Council's "Guide for the Care and Use of Laboratory Animals". Upon receipt at Bldg. 838 the rats will be housed individually with each lot segregated from all other rodents for a 7-10 day quarantine/acclimation period. All animals will be observed at least twice daily by vivarium personnel for general condition and any signs of illness will be recorded. A polycarbonate shoebox caging system with cellulose fiber contact bedding (Cell-Sorb Plus, A.W. Products, Inc., New Philadelphia, OH) will be the primary housing unit. Rats will be changed into freshly bedded and sanitized cages at least once per week. Rodent chow (#5008, Purina Mills, Inc., St. Louis, MO) and fresh conditioned (reverse osmosis) water will be available ad libitum. Prior to surgery all rats will be kept in sanitized animal holding rooms designed to provide 10-15 complete fresh air changes per hour. Room air temperature and humidity will be maintained between 21-26° C and 35-65%. Rodent cage nicks will remain inside Bio-Clean mass air displacement units, which provide a constant supply ofHEPA filtered air. Electronically controlled full spectrum fluorescent light will be provided on a 12:12 hour light: dark cycle. 
